SCM

Suvretta Capital Management Portfolio holdings

AUM $4.01B
1-Year Est. Return 66.2%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+66.2%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.3B
AUM Growth
+$644M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
106
New
Increased
Reduced
Closed

Top Buys

1 +$49.2M
2 +$31.6M
3 +$30.3M
4
MSOS icon
AdvisorShares Pure US Cannabis ETF
MSOS
+$28.2M
5
FERG icon
Ferguson
FERG
+$26.4M

Top Sells

1 +$60.4M
2 +$39.4M
3 +$28.8M
4
DDOG icon
Datadog
DDOG
+$24M
5
ARQT icon
Arcutis Biotherapeutics
ARQT
+$16.7M

Sector Composition

1 Healthcare 60.44%
2 Technology 13.51%
3 Consumer Discretionary 5.97%
4 Financials 5.68%
5 Industrials 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARQT icon
1
Arcutis Biotherapeutics
ARQT
$2.89B
$198M 5.99%
10,478,000
-1,057,582
BNTC icon
2
Benitec Biopharma
BNTC
$358M
$139M 4.2%
9,876,506
META icon
3
Meta Platforms (Facebook)
META
$1.69T
$126M 3.81%
170,973
+1,128
LEGN icon
4
Legend Biotech
LEGN
$3.3B
$125M 3.77%
3,818,009
+44,000
ETNB
5
DELISTED
89bio
ETNB
$122M 3.69%
8,280,000
-5,930,000
IMTX icon
6
Immatics
IMTX
$1.36B
$102M 3.11%
12,030,129
KO icon
7
Coca-Cola
KO
$336B
$96.5M 2.93%
1,455,080
+221,850
GE icon
8
GE Aerospace
GE
$350B
$93.3M 2.83%
310,262
NVDA icon
9
NVIDIA
NVDA
$4.45T
$90.2M 2.74%
483,535
-16,027
EYPT icon
10
EyePoint Inc
EYPT
$1.49B
$88.2M 2.67%
6,192,715
-611,376
BHVN icon
11
Biohaven
BHVN
$1.42B
$84.4M 2.56%
5,620,271
MLYS icon
12
Mineralys Therapeutics
MLYS
$2.26B
$80.9M 2.45%
2,132,133
+387,641
HD icon
13
Home Depot
HD
$365B
$79.9M 2.42%
197,311
+66,590
TSM icon
14
TSMC
TSM
$1.85T
$77.4M 2.35%
277,201
-23,200
KURA icon
15
Kura Oncology
KURA
$740M
$71.8M 2.18%
8,116,000
FERG icon
16
Ferguson
FERG
$49.6B
$68.8M 2.09%
306,260
+116,600
AVBP icon
17
ArriVent BioPharma
AVBP
$988M
$68.3M 2.07%
3,703,452
+290,664
APLS icon
18
Apellis Pharmaceuticals
APLS
$2.54B
$65.1M 1.97%
2,878,000
AMD icon
19
Advanced Micro Devices
AMD
$329B
$64.5M 1.96%
398,799
ORCL icon
20
Oracle
ORCL
$438B
$63.6M 1.93%
226,318
-4,410
RARE icon
21
Ultragenyx Pharmaceutical
RARE
$2.11B
$60.7M 1.84%
2,019,000
-259,000
BAC icon
22
Bank of America
BAC
$363B
$59.9M 1.81%
1,160,330
+233,140
KALV icon
23
KalVista Pharmaceuticals
KALV
$827M
$58.1M 1.76%
4,768,712
-186,288
APO icon
24
Apollo Global Management
APO
$61.9B
$57.5M 1.74%
431,260
+2,800
MSFT icon
25
Microsoft
MSFT
$3.01T
$56.7M 1.72%
109,455
+10,627